| Product Code: ETC7648623 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Complete Androgen Insensitivity Syndrome Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Complete Androgen Insensitivity Syndrome Market - Industry Life Cycle |
3.4 Israel Complete Androgen Insensitivity Syndrome Market - Porter's Five Forces |
3.5 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Complete Androgen Insensitivity Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of complete androgen insensitivity syndrome (CAIS) in Israel |
4.2.2 Advancements in genetic testing and technology leading to improved detection and management of CAIS |
4.2.3 Growing focus on personalized medicine and tailored treatment options for CAIS patients |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of specialized healthcare services for CAIS patients in Israel |
4.3.2 Cultural and societal stigmas surrounding intersex conditions impacting diagnosis and treatment seeking behavior |
4.3.3 High cost associated with genetic testing and long-term management of CAIS |
5 Israel Complete Androgen Insensitivity Syndrome Market Trends |
6 Israel Complete Androgen Insensitivity Syndrome Market, By Types |
6.1 Israel Complete Androgen Insensitivity Syndrome Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Symptoms, 2021- 2031F |
6.1.3 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Abnormally Tall Stature, 2021- 2031F |
6.1.4 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Little or No Pubic Hair, 2021- 2031F |
6.1.5 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Shallow Vagina, 2021- 2031F |
6.1.6 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Undescended Testicles, 2021- 2031F |
6.1.7 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Amenorrhea, 2021- 2031F |
6.1.8 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Complete Androgen Insensitivity Syndrome Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.2.3 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.2.4 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Pelvic Ultrasound, 2021- 2031F |
6.2.5 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Complete Androgen Insensitivity Syndrome Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.3 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Estrogen Replacement Therapy, 2021- 2031F |
6.3.4 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Genetic Counselling, 2021- 2031F |
6.3.5 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Hormone Medications, 2021- 2031F |
6.3.6 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Complete Androgen Insensitivity Syndrome Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Complete Androgen Insensitivity Syndrome Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Complete Androgen Insensitivity Syndrome Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Israel Complete Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Complete Androgen Insensitivity Syndrome Market Import-Export Trade Statistics |
7.1 Israel Complete Androgen Insensitivity Syndrome Market Export to Major Countries |
7.2 Israel Complete Androgen Insensitivity Syndrome Market Imports from Major Countries |
8 Israel Complete Androgen Insensitivity Syndrome Market Key Performance Indicators |
8.1 Average age of diagnosis of CAIS patients in Israel |
8.2 Number of healthcare facilities offering specialized care for CAIS patients |
8.3 Percentage of CAIS patients receiving comprehensive genetic counseling and support |
8.4 Rate of adoption of personalized treatment plans for CAIS individuals |
8.5 Number of research studies and clinical trials focused on improving outcomes for CAIS patients |
9 Israel Complete Androgen Insensitivity Syndrome Market - Opportunity Assessment |
9.1 Israel Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 Israel Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Israel Complete Androgen Insensitivity Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Complete Androgen Insensitivity Syndrome Market - Competitive Landscape |
10.1 Israel Complete Androgen Insensitivity Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Israel Complete Androgen Insensitivity Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here